Biotech

All Articles

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Let's study a chat along with Ayla Ellison, Ferocious Biotech Editor-in-Chief and also Michelle Ben...

New data show how Bayer's asundexian stopped working to avoid movements

.Bayer suspended the phase 3 test for its factor XIa prevention asundexian late in 2015 after the me...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its own several sclerosis (MS) med tolebrutinib to the FD...

Galapagos' stockpile as fund shows intent to form its development

.Galapagos is happening under extra tension coming from real estate investors. Having actually creat...

Cell- focused Sana gathers initial CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of substantial management hirings, firings ...

Allist pays off Jacobio $21M, landing part in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually gotten on its own a starring role in China's KRAS mark...

ReNeuron leaving behind purpose substitution after missing fundraising target

.ReNeuron has joined the long listing of biotechs to leave behind London's intention securities mark...

MBX files for IPO to take opposition to Ascendis right into phase 3

.MBX Biosciences has actually added to the recent outbreak of IPO filings. The biotech, which submit...

FDA expands probing in to Lykos' MDMA trials: WSJ

.For Lykos Rehabs and the provider's potential MDMA-assisted therapy for post-traumatic stress disor...

Gene publisher Volume laying off 131 workers

.Simply days after gene publisher Tome Biosciences declared concealed functional slices, a clearer i...